<span>Labcorp earns top score on 2022 Disability Equality Index</span>
July 22, 2022

Labcorp earns top score on 2022 Disability Equality Index

BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 22, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that it scored 100, the highest score possible, on the 2022 Disability Equality Index® (DEI), a comprehensive benchmarking tool for measuring disability inclusion in the workplace.
Group of people swimming and tubing in a pool

Summer vacation and gathering tips for our third summer of the COVID-19 pandemic

Summer is in full swing! We’ve compiled a few tips to help you feel even more confident in your gathering and travel plans this year.

New Labcorp Test Report Helps Identify Insect Stings and Improve Therapy Decisions to Combat Allergic Reactions

Labcorp Expands Automated Clinical Trial Kit Production Line at European Operations Center

July 14, 2022

Labcorp to announce second quarter financial results on July 28, 2022

BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 14, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, will release its financial results for the second quarter of 2022 before the market opens on Thursday, July 28, 2022 . The company will host a conference call and webcast beginning at 9 a.m. EDT that day to discuss the results.
July 14, 2022

Labcorp declares quarterly dividend

BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 14, 2022-- Labcorp (NYSE: LH) (the Company), a leading global life sciences company, announced today that its Board of Directors (the Board) has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on September 9, 2022 ,